| Literature DB >> 24900603 |
Jérôme Molette1, Julie Routier1, Nada Abla1, Dominique Besson2, Agnes Bombrun1, Reto Brun3, Howard Burt1, Katrin Georgi1, Marcel Kaiser3, Solomon Nwaka2, Mathilde Muzerelle1, Alexander Scheer1.
Abstract
Recent observations on the emergence of artemisinin resistant parasites have highlighted the need for new antimalarial treatments. An HTS campaign led to the identification of the 1-(1-aminopropan-2-ol)carbazole analogues as potent hits against Plasmodium falciparum K1 strain. The SAR study and optimization of early ADME and physicochemical properties direct us to the selection of a late lead compound that shows good efficacy when orally administrated in the in vivo P. berghei mouse model.Entities:
Keywords: IC50; Malaria; Plasmodium berghei; Plasmodium falciparum; SAR; WHO; carbazole; hERG
Year: 2013 PMID: 24900603 PMCID: PMC4027556 DOI: 10.1021/ml400015f
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345